Min.Order / FOB Price:Get Latest Price
25 Kilogram |
FOB Price: USD 708.0000 |
Triacetyluridine Uridine triacetate 4105-38-8
Uridine triacetate Triacetyluridine 4105-38-8
On September 4, 2015, the FDA approved Wellstat's new molecular solid drug, Uridine Triacetate, on the market for oral granules called Xuriden. Used to treat congenital hyperuricemia, a rare form of hereditary whey aciduria, granted orphan drugs and priority review qualifications. Ureaside triacetate is a substitute for urea, urea can promote the body whey acid into urea, thus avoiding the large number of whey acid in the blood and urine.
Bioactive
Uridine triacetate (Vistonuridine, PN401) is an oral active precursor drug for the natural product nucleoside urea. It is used in the treatment of hereditary whey aciduria or in emergency treatments such as fluorouracil, capetamine overdose or toxicity.
Our advantages:
1, High quality with competitive price:
1) Standard:BP/USP/EP/Enterprise standard
2) All Purity≥99%
3) We are manufacturer and can provide high quality products with factory price.
2, Fast and safe delivery
1) Parcel can be sent out in 24 hours after payment.Tracking number available
2) Secure and discreet shipment.Various transportation methods for your choice.
3) Customs pass rate ≥99%
4) We have our own agent/remailer/distributor who can help us ship our products very fast and safe,
and we have stock in there for transferring.
CAS NO:6119-47-7
CAS NO:61-54-1
CAS NO:60-19-5
CAS NO:117048-59-6
CAS NO:16178-48-6
CAS NO:54735-61-4
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View